Russia and India are now jointly going to produce the COVID-19 vaccine Sputnik V. Russian envoy in New Delhi Nikolay Kudashev on Monday said Moscow will jointly produce the Sputnik V vaccine for COVID-19 along with India and it will be manufactured by Indiana pharma Dr. Reddy’s Laboratories.
Kudashev said, addressing a press conference, “We are working very hard to fight COVID-19 together with India, and are; now advancing to jointly produce Sputnik V vaccine at the capacities of Dr. Reddy’s Laboratories and other countries. We have supported each other in a big way earlier this year; when we managed to repatriate thousands of Russian and Indian nationals to their respective home countries.”
On August, 11, Russia became the world’s first country to register a corona virus vaccine, dubbed Sputnik V.
The vaccine was developed by the Gamaleya Research Institute while the Russian Direct Investment Fund (RDIF), Russia’s sovereign in the production and promotion of the vaccine abroad.
Sputnik V vaccine has shown 92% efficacy in preventing COVID-19, according to the interim trial results announced by the country’s health ministry. In September 2020, Dr. Reddy and RDIF entered into a partnership to conduct clinical trials; of the Sputnik V vaccine and its distribution in India.
Kudashev said a lot of efforts are aimed; at coordinating in the international arena, including the World Health Organisation and BRICS, where Russia; has got advanced healthcare Mechanism and initiatives, including Tuberculosis Network, Vaccine Research Centre, and Early Warning System; to prevent the spread of infectious diseases.